Treatment of incontinence with 5HTC2 agonists

Details for Australian Patent Application No. 2004233745 (hide)

Owner Pfizer Inc.

Inventors Miner, Wesley Dennis; McMurray, Gordon

Agent Spruson & Ferguson

Pub. Number AU-B-2004233745

PCT Pub. Number WO2004/096196

Priority 0309533.8 25.04.03 GB

Filing date 21 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 25 March 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/096196 Priority application(s): WO2004/096196

25 March 2010 Application Accepted

  Published as AU-B-2004233745

22 July 2010 Standard Patent Sealed

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233757-Striped liquid personal cleansing compositions containing a cleansing phase and a separate benefit phase comprising a water in oil emulsion

2004233744-Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance